Order Now

Learning Outcomes and Modules  

After completing this course, the learner should be able to:

• Describe techniques for optimal performance and interpretation of lung cancer screening examinations
• Discuss optimal technique for performance and interpretation of CT colonography examinations for colorectal cancer screening
• Describe the latest developments in breast cancer screening, including abbreviated MRI protocols and contrast-enhanced mammography
• Explain various response assessment criteria for solid organ tumors, including RECIST 1.1, iRECIST, and Lugano
• Discuss disparities in cancer screening and strategies to address disparities

Module 1—Lung Cancer Screening, Missed Cases and Staging

• Introduction to Lung Cancer Screening: Advancing Equity in Your Practice—Efren J. Flores, MD
• Approach to Management of Difficult Nodules on Lung Cancer Screening CT—Suzanne C. Byrne, MD
• Thoracic Malignancy Undercalls and Overcalls: A Practical Approach to Improve Accuracy—Lucy Modahl, MD, PhD
• Imaging in Lung Cancer Staging and Modern Lung Cancer Treatment—Dexter Mendoza, MD

Module 2—Lung Cancer Imaging Interventions and Advancements

• Spectrum of Lung Ablation Indications: From Early-Stage Lung Cancer to Palliative Care—Florian J. Fintelmann, MD
• Lung Cancer Treatment: Complications and Pitfalls—Saurabh Agarwal, MD
• Future Advancements in Lung Cancer Care Continuum—Subba R. Digumarthy, MD
• Past, Present, and Future of Lung Cancer Screening—Rydhwana Hossain, MD

Module 3—CT Colonography Technique and Interpretation

• Preparing Patients for CT Colonography—Abraham Dachman, MD
• CT Colonography Radiation Dose: How Low Can You Go?—Kevin J. Chang, MD
• CT Colonography Interpretation—Mariya Kobi, MD
• CT Colonography Pitfalls and How to Avoid Them—Firas Ahmed, MD

Module 4—CT Colonography Registry, Implementation, Rectal MRI

• CT Colonography Registry—Courtney Coursey Moreno, MD
• Practical Implementation of a CT Colonography Service—Cecelia Brewington, MD, FACR
• Rectal Cancer MRI: A Practical User’s Guide to Primary Staging—Zahra M. Kassam, MD
• MRI for Evaluation of Treatment Response in Rectal Cancer—Mukesh G. Harisinghani, MD (2004 Figley Fellow)

Module 5—Breast Cancer: Background History, BI-RADS, Ultrasound

• The History of Screening Mammography—Debra S. Copit, MD
• Digital Breast Tomosynthesis: Background, Benefits, and Future—Sarah M. Friedewald, MD
• Imaging Interval Breast Cancers With Digital Breast Tomosynthesis: Epidemiologic, Biological, and Radiologic Considerations—Melissa A. Durand, MD, MS
• The American College of Radiology BI-RADS Mammography Audit: Situations and Assessments—Donna M. Plecha, MD

Module 6—Breast Cancer: BI-RADS, Tomosynthesis

• Malignant Tumors of the Breast: An Introduction—Hannah Gilmore, MD
• Abbreviated Breast MRI for Supplemental Screening: The Why and How of Clinical Implementation—Emily F. Conant, MD
• Breast Cancer Screening with Ultrasound—Regina Hooley, MD
• Contrast-Enhanced Mammography: Current Applications and Future Directions—Jordana Phillips, MD

Module 7—Breast Cancer: MRI, AI and Pathology

• Anxiety and Psychologic Distress with Breast Cancer Screening—Jessica W.T. Leung, MD
• Disparities in Breast Cancer and Implications for Screening African American Women—Stephanie Patterson, MD
• The Economics of Breast Cancer Screening—Dana H. Smetherman, MD
• Breast Cancer Screening and Imaging Techniques: Artificial Intelligence—Michael D.C. Fishman, MD

Module 8—Response Assessment: RECIST/IRECIST: Immune Therapy

• RECIST 1.1 and RECIST Modifications—Kathleen Laura Ruchalski, MD
• Tips and Pitfalls in RECIST 1.1—Jordan Mossler Anaokar, MD
• A Primer: iRECIST in Immune Therapy—Iva Petkovska, MD
• A Primer: Lymphoma Response Evaluation with PET/CT – The “Lugano” Family—Lacey J. McIntosh, DO, MPH

Module 9—Response Assessment: Workflows, Models, New Horizons

• Setting Up a Workflow for Oncology Treatment Response—Marta Braschi-Amirfarzan, MD
• The Business of Performing Tumor Response Assessment in a Radiology Department—Michael L. Douek, MD
• New Horizons: PET/MRI in Tumor Response—Matthias R. Benz, MD
• New Horizons: The Use of Artificial Intelligence in Tumor Outcomes Assessment—Jonathan G. Goldin, MD, MBChB, PhD